SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001246360-14-002851
Filing Date
2014-06-05
Accepted
2014-06-05 18:42:12
Documents
1
Period of Report
2014-06-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form.html 4  
1 PRIMARY DOCUMENT form.xml 4 3749
  Complete submission text file 0001246360-14-002851.txt   5182
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Issuer) CIK: 0000911326 (see all company filings)

IRS No.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address NEUROGEN CORP 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address
DAVIS STEPHEN (Reporting) CIK: 0001131146 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23155 | Film No.: 14894681